# The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)

> **NCT00713258** · PHASE4 · TERMINATED · sponsor: **Nycomed** · enrollment: 75 (actual)

## Conditions studied

- Back Pain

## Interventions

- **DRUG:** Parathyroid hormone (PTH) (1-84)
- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT00713258
- **Lead sponsor:** Nycomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-04
- **Primary completion:** 2010-05
- **Final completion:** 2010-09
- **Target enrollment:** 75 (ACTUAL)
- **Why stopped:** Slow enrolment
- **Last updated:** 2012-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00713258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00713258, "The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00713258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*